The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 27, 2020

Filed:

Aug. 01, 2017
Applicant:

Jiangsu Hengrui Medicine Co., Ltd., Lianyungang, CN;

Inventors:

Deyu Liu, Lianyungang, CN;

Hongwei Wang, Lianyungang, CN;

Liang Zhao, Lianyungang, CN;

Feifei Wang, Lianyungang, CN;

Xiang Zeng, Lianyungang, CN;

Tao Wang, Lianyungang, CN;

Yali Wang, Lianyungang, CN;

Yulu Dai, Lianyungang, CN;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/28 (2006.01); A61K 47/54 (2017.01); C07K 14/62 (2006.01); C07K 1/06 (2006.01); C07K 1/107 (2006.01); A61P 3/10 (2006.01);
U.S. Cl.
CPC ...
C07K 14/62 (2013.01); A61K 38/28 (2013.01); A61K 47/542 (2017.08); A61P 3/10 (2018.01); C07K 1/06 (2013.01); C07K 1/107 (2013.01); Y02P 20/55 (2015.11);
Abstract

Provided is an acylated derivative of human insulin or an analogue thereof. Specifically disclosed is an acylated derivative of a human insulin analogue, or zinc complex thereof; the human insulin analogue being derivatized is preferably Des(B30) human insulin; the acylated derivative is longer-lasting than existing insulin analogues and acylated derivatives thereof, its blood glucose reduction is more steady, and it is more stable in storage.


Find Patent Forward Citations

Loading…